FDAnews
www.fdanews.com/articles/150927-omthera-pharmaceuticals-presents-data-from-analysis-of-evolve-trial-showing-epanova-lowers-apoc-iii

Omthera Pharmaceuticals Presents Data From Analysis of EVOLVE Trial Showing Epanova Lowers ApoC-III

November 9, 2012
Omthera Pharmaceuticals presented data from the company’s Phase III EVOLVE (EpanoVa fOr Lowering Very High triglyceridEs) trial at the Scientific Sessions of the American Heart Association.
The Sacramento Bee